Added to YB: 2018-07-31
Pitch date: 2018-07-31
SBBP [bullish]
Strongbridge Biopharma plc
-58.33%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
As of October 5, 2021, Strongbridge Biopharma plc was acquired by Xeris Pharmaceuticals, Inc. Strongbridge Biopharma plc, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases with unmet needs in the United States.
Market Cap
$135.7M
Pitch Price
$4.80
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-2.82
EV/Sales
N/A
Sector
Pharmaceuticals
Category
N/A
Show full summary:
Strongbridge SBBP
A summary for this pitch has not been created yet.
Read full article (0 min)